| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 33,004 | 30,091 | 87,678 | 10,869 | | Cost of Revenue | 16,638 | 12,998 | 43,261 | 2,989 | | | Gross Profit | 16,366 | 17,093 | 44,417 | 7,880 | | | Operating Expenses | | Research Development | 7,225 | 5,886 | 6,519 | 6,887 | | Selling General and Administrative | 4,540 | 5,202 | 6,186 | 4,422 | | Non Recurring | (33) | 211 | 346 | (20,940) | | Others | 353 | 344 | 381 | 465 | | | | Total Operating Expenses | 12,085 | 11,643 | 13,432 | (9,166) | | | | Operating Income or Loss | 4,281 | 5,450 | 30,985 | 17,046 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,274 | 1,490 | 2,163 | 1,583 | | Earnings Before Interest And Taxes | 11,555 | 6,940 | 33,148 | 18,629 | | Interest Expense | 345 | 1,503 | 1,528 | 2,743 | | Income Before Tax | 11,210 | 5,437 | 31,620 | 15,886 | | Income Tax Expense | 2,580 | 4,136 | 9,383 | 3,749 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 8,630 | 1,301 | 22,237 | 12,137 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| (16,363) | 134,789 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,630 | 1,301 | 5,874 | 146,926 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,630 | $1,301 | $5,874 | $146,926 |
|
0.20% Nasdaq 
Income Statement
